Big Pharma issues warning over Europe’s drug industry |
Major European drugmakers, including AstraZeneca, GSK, Novo Nordisk, Sanofi, Roche and Novartis, warn that Europe’s pharmaceutical sector risks long-term decline. In an open letter to the national leaders of European countries, the chairs of nine companies said the region is falling behind the US and China in research, development and investment, and called for urgent action to protect the industry. “In our boardrooms, we see Europe losing ground to global competition. Over $600bn in pharmaceutical investment has been announced in the US and China in the last two years alone . . . European governments must create conditions that attract investment in next-generation medicines before it’s too late,” said the letter, which is entitled Europe is Losing the Pharma Investment Race – But the Comeback is Within Reach.